Lianpeng Chang
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Molecular Biology
- Pathology and Forensic Medicine top 5%
- Topics
- Cancer Genomics and Diagnostics (29 papers)Lung Cancer Treatments and Mutations (16 papers)Pancreatic and Hepatic Oncology Research (7 papers)
- Cited by
- Cancer ResearchOncologyHepatology
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Lianpeng Chang
40 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Oncology 723
- Pulmonary and Respiratory Medicine 556
- Cancer Research 520
- Molecular Biology 275
- Pathology and Forensic Medicine 241
Countries citing papers authored by Lianpeng Chang
This map shows the geographic impact of Lianpeng Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianpeng Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianpeng Chang more than expected).
Fields of papers citing papers by Lianpeng Chang
This network shows the impact of papers produced by Lianpeng Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianpeng Chang. The network helps show where Lianpeng Chang may publish in the future.
Co-authorship network of co-authors of Lianpeng Chang
This figure shows the co-authorship network connecting the top 25 collaborators of Lianpeng Chang. A scholar is included among the top collaborators of Lianpeng Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianpeng Chang. Lianpeng Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patientsbreakdown → | 201 |
| 5 | 7 | |
| 6 | 17 | |
| 7 | 2 | |
| 8 | 8 | |
| 9 | 31 | |
| 10 | 18 | |
| 11 | 49 | |
| 12 | 50 | |
| 13 | 62 | |
| 14 | 63 | |
| 15 | 30 | |
| 16 | 36 | |
| 17 | Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Studybreakdown → | 368 |
| 18 | 9 | |
| 19 | 21 | |
| 20 | 27 |
About Lianpeng Chang
Lianpeng Chang is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 40 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (29 papers), Lung Cancer Treatments and Mutations (16 papers) and Pancreatic and Hepatic Oncology Research (7 papers). The work is most often cited by research in Cancer Research (520 citations), Oncology (723 citations) and Hepatology (165 citations). Lianpeng Chang has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Yanfang Guan, Xin Yi, Xuefeng Xia, Rongrui Liu, Yaping Xu, Yun Zhang, Zhiyuan Hu, Gairong Zhang, Ru Jia and Yan Wang. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.